Skip to main content
Premium Trial:

Request an Annual Quote

New Horizons in Silicon Valley

Things must be going well for Affymax, biopharma and birthplace of Affymetrix. The company, which had its IPO recently and has entered clinical trials with its lead candidate, just expanded its office space by more than 30,000 square feet -- that's an increase of over 50 percent from its prior space -- according to this article in the Silicon Valley / San Jose Business Journal.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.